ReviewFrontiers in oncology2021

Immunotherapy for Head and Neck Cancer: A Paradigm Shift From Induction Chemotherapy to Neoadjuvant Immunotherapy.

Hirofumi Shibata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.